Clinical trial
Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or…
NCT00492037 · Cumberland Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00492037 |
|---|---|
| Title | Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia |
| Official title | A 5-Day, Double-Blind, Placebo-Controlled Multicenter Study of Oral YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia |
| Lead sponsor | Cumberland Pharmaceuticals, Industry |
| Collaborators | Parke-Davis Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyponatremia |
| Intervention type | Drug |
| Interventions | YM087 oral |
| Enrollment | 83 |
| Start date | Jan 1, 2000 |
| Completion | Feb 1, 2002 |
| First posted | Jun 27, 2007 |
| Last update posted | May 2, 2014 |
| Countries | Belgium, Finland, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: